Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

Hospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes are not fully understood and data addressing the use of illness severity scores in prognostication are limited. To investigate the use of CUR...

Full description

Saved in:
Bibliographic Details
Published inRespiratory medicine Vol. 212; p. 107220
Main Authors Williams, Rachel L., Hyams, Catherine, Robertshaw, Joe, Gonzalez, Maria Garcia, Szasz-Benczur, Zsuzsa, White, Paul, Maskell, Nick A., Finn, Adam, Barratt, Shaney L., Adegbite, David, Antico, Rupert, Bayley, Francesca, Begier, Beth, Bellavia, Maddalena, Bridgeman, Emma, Brzezinska, Julia, Campling, James, Chang, Natalie, Cloake, Julie, Clout, Madeleine, Croxford, Pip, Ellsbury, Gillian, Gessner, Bradford, Grace, Niall, Gray, Sharon, Griffiths, Oliver, Grimes, Charli, Grimwood, Lucy, Friedrich, Zsolt, Fleming, Leah, Fox, Kazminder, Jeenes-Flanagan, Milo, Jodar, Luis, Wright, Johanna Kellett, Kinney, Jane, Heath, Robyn, Helliker, Kate, Huber, Robyn, Langdon, Amelia, Lazarus, Rajeka, Arachchge, Sandi Nammuni, Mackay, Vicki, Marlow, Robin, Maseko, Zandile, Mattocks, Anya, Maughan, Katie, Manning, Nicola, Milutinovic, Katarina, Minou, Konstantina, Morley, Anna, Mona, Taslima, Mitchell, Claire, Morrison, Leigh, Osborne, Bethany, Perkins, Fiona, Riaz, Tawassal, Ruffino, Gabriella, Sequenza, Peter, Smart, Lily, Scott, Emma, Southern, Jo, Suppiah, Seevakumar, Taylor, Zoe, Tilzey, Grace, Turner, Anabella, Valentine, Gabriella, Vasquez, Marianne, Walters, Rhian, Ward, Lana, Wright, Louise
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes are not fully understood and data addressing the use of illness severity scores in prognostication are limited. To investigate the use of CURB-65 and NEWS-2 severity scores in the prediction of mortality following ARD-ILD hospitalisation, using prospective methodology and to validate previously determined cut-offs, derived from a retrospective study cohort. A dual-centre prospective observational cohort study of all adults (≥18y) hospitalised with ARD-ILD in Bristol, UK (n = 179). Gender-Age-Physiology (GAP), CURB-65 and NEWS-2 scores were calculated for each eligible admission. Receiver operating characteristics (ROC) curve analysis was used to quantify the strength of discrimination for NEWS-2 and CURB-65 scores. Univariable and multivariable logistic regression analyses were performed to explore the relationship between baseline severity scores and mortality. GAP showed some merit at predicting 30-day mortality (AUC = 0.64, P = 0.015); whereas CURB-65 showed modest predictive value for in-hospital (AUC = 0.72, P < 0.001) and 90-day mortality (AUC = 0.67, P < 0.001). NEWS-2 showed higher predictive value for in-hospital (AUC = 0.80, P < 0.001) and 90-day mortality (AUC = 0.75, P < 0.001), with an optimal derived cut-off ≥6.5 found to be sensitive and specific for predicting in-hospital (83% and 63%) and 90-day (73% and 72%) mortality. In exploratory analyses, GAP score addition improved the predictive ability of NEWS-2 against 30-day mortality and CURB-65 across all time-periods. NEWS-2 has good discriminatory value for predicting in-hospital mortality and moderate discriminatory value for predicting 90-day mortality. The optimal NEWS-2 cut-off value determined was the same as in a previous retrospective cohort, confirming the NEWS-2 score shows promise in predicting mortality following ARD-ILD hospitalisation. •ARD-ILD is associated with high in-hospital, 30- and 90- day mortality, irrespective of cause.•NEWS-2 has high sensitivity and specificity in predicting 90d & in-hospital mortality in ARD-ILD.•CURB-65 showed high sensitivity for predicting mortality but low specificity.•CURB-65 did not add value to the NEWS-2 predictive ability.•Simple illness severity scores may support refinement of ARD-ILD management pathways.
AbstractList INTRODUCTIONHospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes are not fully understood and data addressing the use of illness severity scores in prognostication are limited. OBJECTIVETo investigate the use of CURB-65 and NEWS-2 severity scores in the prediction of mortality following ARD-ILD hospitalisation, using prospective methodology and to validate previously determined cut-offs, derived from a retrospective study cohort. METHODSA dual-centre prospective observational cohort study of all adults (≥18y) hospitalised with ARD-ILD in Bristol, UK (n = 179). Gender-Age-Physiology (GAP), CURB-65 and NEWS-2 scores were calculated for each eligible admission. Receiver operating characteristics (ROC) curve analysis was used to quantify the strength of discrimination for NEWS-2 and CURB-65 scores. Univariable and multivariable logistic regression analyses were performed to explore the relationship between baseline severity scores and mortality. RESULTSGAP showed some merit at predicting 30-day mortality (AUC = 0.64, P = 0.015); whereas CURB-65 showed modest predictive value for in-hospital (AUC = 0.72, P < 0.001) and 90-day mortality (AUC = 0.67, P < 0.001). NEWS-2 showed higher predictive value for in-hospital (AUC = 0.80, P < 0.001) and 90-day mortality (AUC = 0.75, P < 0.001), with an optimal derived cut-off ≥6.5 found to be sensitive and specific for predicting in-hospital (83% and 63%) and 90-day (73% and 72%) mortality. In exploratory analyses, GAP score addition improved the predictive ability of NEWS-2 against 30-day mortality and CURB-65 across all time-periods. CONCLUSIONNEWS-2 has good discriminatory value for predicting in-hospital mortality and moderate discriminatory value for predicting 90-day mortality. The optimal NEWS-2 cut-off value determined was the same as in a previous retrospective cohort, confirming the NEWS-2 score shows promise in predicting mortality following ARD-ILD hospitalisation.
Hospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes are not fully understood and data addressing the use of illness severity scores in prognostication are limited. To investigate the use of CURB-65 and NEWS-2 severity scores in the prediction of mortality following ARD-ILD hospitalisation, using prospective methodology and to validate previously determined cut-offs, derived from a retrospective study cohort. A dual-centre prospective observational cohort study of all adults (≥18y) hospitalised with ARD-ILD in Bristol, UK (n = 179). Gender-Age-Physiology (GAP), CURB-65 and NEWS-2 scores were calculated for each eligible admission. Receiver operating characteristics (ROC) curve analysis was used to quantify the strength of discrimination for NEWS-2 and CURB-65 scores. Univariable and multivariable logistic regression analyses were performed to explore the relationship between baseline severity scores and mortality. GAP showed some merit at predicting 30-day mortality (AUC = 0.64, P = 0.015); whereas CURB-65 showed modest predictive value for in-hospital (AUC = 0.72, P < 0.001) and 90-day mortality (AUC = 0.67, P < 0.001). NEWS-2 showed higher predictive value for in-hospital (AUC = 0.80, P < 0.001) and 90-day mortality (AUC = 0.75, P < 0.001), with an optimal derived cut-off ≥6.5 found to be sensitive and specific for predicting in-hospital (83% and 63%) and 90-day (73% and 72%) mortality. In exploratory analyses, GAP score addition improved the predictive ability of NEWS-2 against 30-day mortality and CURB-65 across all time-periods. NEWS-2 has good discriminatory value for predicting in-hospital mortality and moderate discriminatory value for predicting 90-day mortality. The optimal NEWS-2 cut-off value determined was the same as in a previous retrospective cohort, confirming the NEWS-2 score shows promise in predicting mortality following ARD-ILD hospitalisation. •ARD-ILD is associated with high in-hospital, 30- and 90- day mortality, irrespective of cause.•NEWS-2 has high sensitivity and specificity in predicting 90d & in-hospital mortality in ARD-ILD.•CURB-65 showed high sensitivity for predicting mortality but low specificity.•CURB-65 did not add value to the NEWS-2 predictive ability.•Simple illness severity scores may support refinement of ARD-ILD management pathways.
Hospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes are not fully understood and data addressing the use of illness severity scores in prognostication are limited. To investigate the use of CURB-65 and NEWS-2 severity scores in the prediction of mortality following ARD-ILD hospitalisation, using prospective methodology and to validate previously determined cut-offs, derived from a retrospective study cohort. A dual-centre prospective observational cohort study of all adults (≥18y) hospitalised with ARD-ILD in Bristol, UK (n = 179). Gender-Age-Physiology (GAP), CURB-65 and NEWS-2 scores were calculated for each eligible admission. Receiver operating characteristics (ROC) curve analysis was used to quantify the strength of discrimination for NEWS-2 and CURB-65 scores. Univariable and multivariable logistic regression analyses were performed to explore the relationship between baseline severity scores and mortality. GAP showed some merit at predicting 30-day mortality (AUC = 0.64, P = 0.015); whereas CURB-65 showed modest predictive value for in-hospital (AUC = 0.72, P < 0.001) and 90-day mortality (AUC = 0.67, P < 0.001). NEWS-2 showed higher predictive value for in-hospital (AUC = 0.80, P < 0.001) and 90-day mortality (AUC = 0.75, P < 0.001), with an optimal derived cut-off ≥6.5 found to be sensitive and specific for predicting in-hospital (83% and 63%) and 90-day (73% and 72%) mortality. In exploratory analyses, GAP score addition improved the predictive ability of NEWS-2 against 30-day mortality and CURB-65 across all time-periods. NEWS-2 has good discriminatory value for predicting in-hospital mortality and moderate discriminatory value for predicting 90-day mortality. The optimal NEWS-2 cut-off value determined was the same as in a previous retrospective cohort, confirming the NEWS-2 score shows promise in predicting mortality following ARD-ILD hospitalisation.
ArticleNumber 107220
Author Adegbite, David
Begier, Beth
Manning, Nicola
Brzezinska, Julia
Mona, Taslima
Szasz-Benczur, Zsuzsa
Maskell, Nick A.
Fox, Kazminder
Finn, Adam
Suppiah, Seevakumar
Walters, Rhian
Turner, Anabella
Ward, Lana
Robertshaw, Joe
Morrison, Leigh
Perkins, Fiona
Hyams, Catherine
Jodar, Luis
Helliker, Kate
Grimwood, Lucy
Riaz, Tawassal
Osborne, Bethany
Maseko, Zandile
Southern, Jo
Gonzalez, Maria Garcia
Arachchge, Sandi Nammuni
Smart, Lily
Langdon, Amelia
Lazarus, Rajeka
Morley, Anna
Mattocks, Anya
Sequenza, Peter
Antico, Rupert
Campling, James
Ellsbury, Gillian
Grace, Niall
Fleming, Leah
Huber, Robyn
Scott, Emma
Grimes, Charli
Kinney, Jane
Vasquez, Marianne
Heath, Robyn
Marlow, Robin
Wright, Louise
Bayley, Francesca
Mackay, Vicki
Cloake, Julie
Taylor, Zoe
White, Paul
Griffiths, Oliver
Ruffino, Gabriella
Tilzey, Grace
Maughan, Katie
Williams, Rachel L.
Wright, Johanna Kellett
Valentine, Gabriella
Minou, Konstantina
Bellavia, Maddalena
Clout, Madeleine
Bridgeman, Emma
Gessner, Bradford
Gray, Sharon
Chang, Natalie
Milutinovic, Katarina
Friedrich, Zsolt
Mitchell, C
Author_xml – sequence: 1
  givenname: Rachel L.
  surname: Williams
  fullname: Williams, Rachel L.
  organization: Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB, UK
– sequence: 2
  givenname: Catherine
  orcidid: 0000-0003-3923-1773
  surname: Hyams
  fullname: Hyams, Catherine
  organization: Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB, UK
– sequence: 3
  givenname: Joe
  surname: Robertshaw
  fullname: Robertshaw, Joe
  organization: Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB, UK
– sequence: 4
  givenname: Maria Garcia
  surname: Gonzalez
  fullname: Gonzalez, Maria Garcia
  organization: Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, BS2 8AE, UK
– sequence: 5
  givenname: Zsuzsa
  surname: Szasz-Benczur
  fullname: Szasz-Benczur, Zsuzsa
  organization: Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, BS2 8AE, UK
– sequence: 6
  givenname: Paul
  orcidid: 0000-0002-7503-9896
  surname: White
  fullname: White, Paul
  organization: University of the West of England, Bristol, BS16 1QY, UK
– sequence: 7
  givenname: Nick A.
  surname: Maskell
  fullname: Maskell, Nick A.
  organization: Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB, UK
– sequence: 8
  givenname: Adam
  surname: Finn
  fullname: Finn, Adam
  organization: Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, BS2 8AE, UK
– sequence: 9
  givenname: Shaney L.
  orcidid: 0000-0003-3067-7349
  surname: Barratt
  fullname: Barratt, Shaney L.
  email: shaney.barratt@nbt.nhs.uk
  organization: Academic Respiratory Unit, University of Bristol, North Bristol NHS Trust, Southmead, Bristol, BS10 5NB, UK
– sequence: 10
  givenname: David
  surname: Adegbite
  fullname: Adegbite, David
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 11
  givenname: Rupert
  surname: Antico
  fullname: Antico, Rupert
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 12
  givenname: Francesca
  surname: Bayley
  fullname: Bayley, Francesca
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 13
  givenname: Beth
  surname: Begier
  fullname: Begier, Beth
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 14
  givenname: Maddalena
  surname: Bellavia
  fullname: Bellavia, Maddalena
  organization: North Bristol NHS Trust, UK
– sequence: 15
  givenname: Emma
  surname: Bridgeman
  fullname: Bridgeman, Emma
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 16
  givenname: Julia
  surname: Brzezinska
  fullname: Brzezinska, Julia
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 17
  givenname: James
  surname: Campling
  fullname: Campling, James
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 18
  givenname: Natalie
  surname: Chang
  fullname: Chang, Natalie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 19
  givenname: Julie
  surname: Cloake
  fullname: Cloake, Julie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 20
  givenname: Madeleine
  surname: Clout
  fullname: Clout, Madeleine
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 21
  givenname: Pip
  surname: Croxford
  fullname: Croxford, Pip
  organization: North Bristol NHS Trust, UK
– sequence: 22
  givenname: Gillian
  surname: Ellsbury
  fullname: Ellsbury, Gillian
  organization: Vaccines Medical Development, Scientific & Clinical Affairs, Pfizer Inc, UK
– sequence: 23
  givenname: Bradford
  surname: Gessner
  fullname: Gessner, Bradford
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 24
  givenname: Niall
  surname: Grace
  fullname: Grace, Niall
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 25
  givenname: Sharon
  surname: Gray
  fullname: Gray, Sharon
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 26
  givenname: Oliver
  surname: Griffiths
  fullname: Griffiths, Oliver
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 27
  givenname: Charli
  surname: Grimes
  fullname: Grimes, Charli
  organization: North Bristol NHS Trust, UK
– sequence: 28
  givenname: Lucy
  surname: Grimwood
  fullname: Grimwood, Lucy
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 29
  givenname: Zsolt
  surname: Friedrich
  fullname: Friedrich, Zsolt
  organization: North Bristol NHS Trust, UK
– sequence: 30
  givenname: Leah
  surname: Fleming
  fullname: Fleming, Leah
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 31
  givenname: Kazminder
  surname: Fox
  fullname: Fox, Kazminder
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 32
  givenname: Milo
  surname: Jeenes-Flanagan
  fullname: Jeenes-Flanagan, Milo
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 33
  givenname: Luis
  surname: Jodar
  fullname: Jodar, Luis
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 34
  givenname: Johanna Kellett
  surname: Wright
  fullname: Wright, Johanna Kellett
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 35
  givenname: Jane
  surname: Kinney
  fullname: Kinney, Jane
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 36
  givenname: Robyn
  surname: Heath
  fullname: Heath, Robyn
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 37
  givenname: Kate
  surname: Helliker
  fullname: Helliker, Kate
  organization: North Bristol NHS Trust, UK
– sequence: 38
  givenname: Robyn
  surname: Huber
  fullname: Huber, Robyn
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 39
  givenname: Amelia
  surname: Langdon
  fullname: Langdon, Amelia
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 40
  givenname: Rajeka
  surname: Lazarus
  fullname: Lazarus, Rajeka
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 41
  givenname: Sandi Nammuni
  surname: Arachchge
  fullname: Arachchge, Sandi Nammuni
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 42
  givenname: Vicki
  surname: Mackay
  fullname: Mackay, Vicki
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 43
  givenname: Robin
  surname: Marlow
  fullname: Marlow, Robin
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 44
  givenname: Zandile
  surname: Maseko
  fullname: Maseko, Zandile
  organization: North Bristol NHS Trust, UK
– sequence: 45
  givenname: Anya
  surname: Mattocks
  fullname: Mattocks, Anya
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 46
  givenname: Katie
  surname: Maughan
  fullname: Maughan, Katie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 47
  givenname: Nicola
  surname: Manning
  fullname: Manning, Nicola
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 48
  givenname: Katarina
  surname: Milutinovic
  fullname: Milutinovic, Katarina
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 49
  givenname: Konstantina
  surname: Minou
  fullname: Minou, Konstantina
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 50
  givenname: Anna
  surname: Morley
  fullname: Morley, Anna
  organization: North Bristol NHS Trust, UK
– sequence: 51
  givenname: Taslima
  surname: Mona
  fullname: Mona, Taslima
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 52
  givenname: Claire
  surname: Mitchell
  fullname: Mitchell, Claire
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 53
  givenname: Leigh
  surname: Morrison
  fullname: Morrison, Leigh
  organization: North Bristol NHS Trust, UK
– sequence: 54
  givenname: Bethany
  surname: Osborne
  fullname: Osborne, Bethany
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 55
  givenname: Fiona
  surname: Perkins
  fullname: Perkins, Fiona
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 56
  givenname: Tawassal
  surname: Riaz
  fullname: Riaz, Tawassal
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 57
  givenname: Gabriella
  surname: Ruffino
  fullname: Ruffino, Gabriella
  organization: North Bristol NHS Trust, UK
– sequence: 58
  givenname: Peter
  surname: Sequenza
  fullname: Sequenza, Peter
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 59
  givenname: Lily
  surname: Smart
  fullname: Smart, Lily
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 60
  givenname: Emma
  surname: Scott
  fullname: Scott, Emma
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 61
  givenname: Jo
  surname: Southern
  fullname: Southern, Jo
  organization: Vaccines Medical Development, Scientific & Clinical Affairs, Pfizer Inc, UK
– sequence: 62
  givenname: Seevakumar
  surname: Suppiah
  fullname: Suppiah, Seevakumar
  organization: North Bristol NHS Trust, UK
– sequence: 63
  givenname: Zoe
  surname: Taylor
  fullname: Taylor, Zoe
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 64
  givenname: Grace
  surname: Tilzey
  fullname: Tilzey, Grace
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 65
  givenname: Anabella
  surname: Turner
  fullname: Turner, Anabella
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 66
  givenname: Gabriella
  surname: Valentine
  fullname: Valentine, Gabriella
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 67
  givenname: Marianne
  surname: Vasquez
  fullname: Vasquez, Marianne
  organization: North Bristol NHS Trust, UK
– sequence: 68
  givenname: Rhian
  surname: Walters
  fullname: Walters, Rhian
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 69
  givenname: Lana
  surname: Ward
  fullname: Ward, Lana
  organization: North Bristol NHS Trust, UK
– sequence: 70
  givenname: Louise
  surname: Wright
  fullname: Wright, Louise
  organization: North Bristol NHS Trust, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36997098$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAUhUVJaCZJX6CLomU3nkiWLI-gmxLaJhDIplkL_Vw3GjyWqyunzDP0pSszybYgENI954N7ziU5m9IEhHzkbMsZVzf7bT5A2LasFfWjb1v2jmx4J9pGMCXPyIbpTjaKc35BLhH3jDEtJXtPLoTSumd6tyF_nxBoGmgcxwkQKcIL5FiOFH3KgLQkOmcI0Rd6SLnYcZ3FqZ4CGUss0Y50XKZfNEQEW2GzLRGmgvQ54RxXB0Kgf2J5ptYvBWjFzjHbkvKRBqiYmOorpumanA92RPjwel-Rp-_fft7eNQ-PP-5vvz40XnS8NEp47l0PXisIftg5znvHNVNaeeislK5zcghOuQCgmG6FlVoLG6TqubMgrsjnE3fO6fcCWMwhoodxtBOkBU3ba6F3mum-StuT1OeEmGEwc44Hm4-GM7OWYPZmLcGsJZhTCdX06ZW_uHX2ZnlLvQq-nARQt3yJkA36mpmvOWfwxYQU_8f_BxYZnz4
Cites_doi 10.1186/1465-9921-14-73
10.1164/rccm.200703-463PP
10.3949/ccjm.87a.ccc026
10.1513/AnnalsATS.201403-102OC
10.1136/thorax.58.5.377
10.1016/j.chest.2021.06.049
10.1038/s41598-021-83381-z
10.1111/resp.12862
10.1183/09059180.00002114
10.15441/ceem.19.036
10.1183/16000617.0071-2018
10.1371/journal.pone.0255659
10.1111/j.1440-1843.2010.01866.x
10.1016/j.jbi.2008.08.010
10.1093/qjmed/hcaa214
10.1164/rccm.202007-2794OC
10.1186/s12931-019-1037-7
10.1016/j.chest.2015.12.026
10.1097/CCM.0000000000002000
10.1164/rccm.202006-2441LE
10.1371/journal.pone.0242860
10.1136/emermed-2020-210380
10.7326/0003-4819-156-10-201205150-00004
10.1111/resp.13682
10.1148/radiology.143.1.7063747
10.1164/rccm.201604-0801CI
10.1016/j.rmed.2018.09.011
10.1183/09031936.00159709
10.1371/journal.pone.0166462
10.1186/s12890-019-0960-1
10.1108/IJHCQA-07-2015-0086
10.1183/16000617.0050-2017
ContentType Journal Article
Contributor Adegbite, David
Begier, Beth
Manning, Nicola
Brzezinska, Julia
Mona, Taslima
Fox, Kazminder
Suppiah, Seevakumar
Walters, Rhian
Turner, Anabella
Ward, Lana
Morrison, Leigh
Perkins, Fiona
Jodar, Luis
Helliker, Kate
Grimwood, Lucy
Riaz, Tawassal
Osborne, Bethany
Maseko, Zandile
Southern, Jo
Arachchge, Sandi Nammuni
Smart, Lily
Langdon, Amelia
Lazarus, Rajeka
Morley, Anna
Mattocks, Anya
Sequenza, Peter
Antico, Rupert
Campling, James
Ellsbury, Gillian
Grace, Niall
Fleming, Leah
Huber, Robyn
Scott, Emma
Grimes, Charli
Kinney, Jane
Vasquez, Marianne
Heath, Robyn
Marlow, Robin
Wright, Louise
Bayley, Francesca
Mackay, Vicki
Cloake, Julie
Taylor, Zoe
Griffiths, Oliver
Ruffino, Gabriella
Tilzey, Grace
Maughan, Katie
Wright, Johanna Kellett
Valentine, Gabriella
Minou, Konstantina
Bellavia, Maddalena
Clout, Madeleine
Bridgeman, Emma
Gessner, Bradford
Gray, Sharon
Chang, Natalie
Milutinovic, Katarina
Friedrich, Zsolt
Mitchell, Claire
Croxford, Pip
Jeenes-Flanagan, Milo
Contributor_xml – sequence: 1
  givenname: David
  surname: Adegbite
  fullname: Adegbite, David
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 2
  givenname: Rupert
  surname: Antico
  fullname: Antico, Rupert
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 3
  givenname: Francesca
  surname: Bayley
  fullname: Bayley, Francesca
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 4
  givenname: Beth
  surname: Begier
  fullname: Begier, Beth
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 5
  givenname: Maddalena
  surname: Bellavia
  fullname: Bellavia, Maddalena
  organization: North Bristol NHS Trust, UK
– sequence: 6
  givenname: Emma
  surname: Bridgeman
  fullname: Bridgeman, Emma
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 7
  givenname: Julia
  surname: Brzezinska
  fullname: Brzezinska, Julia
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 8
  givenname: James
  surname: Campling
  fullname: Campling, James
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 9
  givenname: Natalie
  surname: Chang
  fullname: Chang, Natalie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 10
  givenname: Julie
  surname: Cloake
  fullname: Cloake, Julie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 11
  givenname: Madeleine
  surname: Clout
  fullname: Clout, Madeleine
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 12
  givenname: Pip
  surname: Croxford
  fullname: Croxford, Pip
  organization: North Bristol NHS Trust, UK
– sequence: 13
  givenname: Gillian
  surname: Ellsbury
  fullname: Ellsbury, Gillian
  organization: Vaccines Medical Development, Scientific & Clinical Affairs, Pfizer Inc, UK
– sequence: 14
  givenname: Bradford
  surname: Gessner
  fullname: Gessner, Bradford
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 15
  givenname: Niall
  surname: Grace
  fullname: Grace, Niall
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 16
  givenname: Sharon
  surname: Gray
  fullname: Gray, Sharon
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 17
  givenname: Oliver
  surname: Griffiths
  fullname: Griffiths, Oliver
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 18
  givenname: Charli
  surname: Grimes
  fullname: Grimes, Charli
  organization: North Bristol NHS Trust, UK
– sequence: 19
  givenname: Lucy
  surname: Grimwood
  fullname: Grimwood, Lucy
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 20
  givenname: Zsolt
  surname: Friedrich
  fullname: Friedrich, Zsolt
  organization: North Bristol NHS Trust, UK
– sequence: 21
  givenname: Leah
  surname: Fleming
  fullname: Fleming, Leah
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 22
  givenname: Kazminder
  surname: Fox
  fullname: Fox, Kazminder
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 23
  givenname: Milo
  surname: Jeenes-Flanagan
  fullname: Jeenes-Flanagan, Milo
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 24
  givenname: Luis
  surname: Jodar
  fullname: Jodar, Luis
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 25
  givenname: Johanna Kellett
  surname: Wright
  fullname: Wright, Johanna Kellett
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 26
  givenname: Jane
  surname: Kinney
  fullname: Kinney, Jane
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 27
  givenname: Robyn
  surname: Heath
  fullname: Heath, Robyn
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 28
  givenname: Kate
  surname: Helliker
  fullname: Helliker, Kate
  organization: North Bristol NHS Trust, UK
– sequence: 29
  givenname: Robyn
  surname: Huber
  fullname: Huber, Robyn
  organization: Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, USA
– sequence: 30
  givenname: Amelia
  surname: Langdon
  fullname: Langdon, Amelia
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 31
  givenname: Rajeka
  surname: Lazarus
  fullname: Lazarus, Rajeka
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 32
  givenname: Sandi Nammuni
  surname: Arachchge
  fullname: Arachchge, Sandi Nammuni
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 33
  givenname: Vicki
  surname: Mackay
  fullname: Mackay, Vicki
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 34
  givenname: Robin
  surname: Marlow
  fullname: Marlow, Robin
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 35
  givenname: Zandile
  surname: Maseko
  fullname: Maseko, Zandile
  organization: North Bristol NHS Trust, UK
– sequence: 36
  givenname: Anya
  surname: Mattocks
  fullname: Mattocks, Anya
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 37
  givenname: Katie
  surname: Maughan
  fullname: Maughan, Katie
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 38
  givenname: Nicola
  surname: Manning
  fullname: Manning, Nicola
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 39
  givenname: Katarina
  surname: Milutinovic
  fullname: Milutinovic, Katarina
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 40
  givenname: Konstantina
  surname: Minou
  fullname: Minou, Konstantina
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 41
  givenname: Anna
  surname: Morley
  fullname: Morley, Anna
  organization: North Bristol NHS Trust, UK
– sequence: 42
  givenname: Taslima
  surname: Mona
  fullname: Mona, Taslima
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 43
  givenname: Claire
  surname: Mitchell
  fullname: Mitchell, Claire
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 44
  givenname: Leigh
  surname: Morrison
  fullname: Morrison, Leigh
  organization: North Bristol NHS Trust, UK
– sequence: 45
  givenname: Bethany
  surname: Osborne
  fullname: Osborne, Bethany
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 46
  givenname: Fiona
  surname: Perkins
  fullname: Perkins, Fiona
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 47
  givenname: Tawassal
  surname: Riaz
  fullname: Riaz, Tawassal
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 48
  givenname: Gabriella
  surname: Ruffino
  fullname: Ruffino, Gabriella
  organization: North Bristol NHS Trust, UK
– sequence: 49
  givenname: Peter
  surname: Sequenza
  fullname: Sequenza, Peter
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 50
  givenname: Lily
  surname: Smart
  fullname: Smart, Lily
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 51
  givenname: Emma
  surname: Scott
  fullname: Scott, Emma
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 52
  givenname: Jo
  surname: Southern
  fullname: Southern, Jo
  organization: Vaccines Medical Development, Scientific & Clinical Affairs, Pfizer Inc, UK
– sequence: 53
  givenname: Seevakumar
  surname: Suppiah
  fullname: Suppiah, Seevakumar
  organization: North Bristol NHS Trust, UK
– sequence: 54
  givenname: Zoe
  surname: Taylor
  fullname: Taylor, Zoe
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 55
  givenname: Grace
  surname: Tilzey
  fullname: Tilzey, Grace
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 56
  givenname: Anabella
  surname: Turner
  fullname: Turner, Anabella
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 57
  givenname: Gabriella
  surname: Valentine
  fullname: Valentine, Gabriella
  organization: Bristol Vaccine Centre, University of Bristol, UK
– sequence: 58
  givenname: Marianne
  surname: Vasquez
  fullname: Vasquez, Marianne
  organization: North Bristol NHS Trust, UK
– sequence: 59
  givenname: Rhian
  surname: Walters
  fullname: Walters, Rhian
  organization: Clinical Research and Imaging Centre, UHBW NHS Trust, UK
– sequence: 60
  givenname: Lana
  surname: Ward
  fullname: Ward, Lana
  organization: North Bristol NHS Trust, UK
– sequence: 61
  givenname: Louise
  surname: Wright
  fullname: Wright, Louise
  organization: North Bristol NHS Trust, UK
Copyright 2023 The Authors
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2023 The Authors
– notice: Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
CorporateAuthor AvonCAP Research Group
CorporateAuthor_xml – name: AvonCAP Research Group
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.rmed.2023.107220
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-3064
EndPage 107220
ExternalDocumentID 10_1016_j_rmed_2023_107220
36997098
S0954611123001087
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29P
3O-
3V.
4.4
457
4G.
53G
5RE
5VS
6I.
7-5
71M
7RV
7X7
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABOCM
ABVKL
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFFNX
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
BENPR
BKEYQ
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
CAG
COF
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
IHE
IXB
J1W
K-O
KOM
L7B
LCYCR
M0T
M29
M2O
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OI-
OK1
OU.
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
RSU
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
SV3
T5K
UHS
UV1
WH7
WOW
WUQ
X7M
Z5R
ZA5
ZGI
ZXP
~G-
0SF
AAXKI
ADVLN
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c351t-63c1cb7ec96edcf8b117b190696ce5a44b5b4fdb6bdee60923a4993ad4671bae3
IEDL.DBID AIKHN
ISSN 0954-6111
IngestDate Sat Oct 05 04:29:32 EDT 2024
Thu Sep 26 17:11:19 EDT 2024
Sat Sep 28 08:13:36 EDT 2024
Fri Feb 23 02:37:20 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Pulmonary fibrosis
Interstitial lung disease
Acute respiratory deterioration
Severity scores
Language English
License This is an open access article under the CC BY license.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c351t-63c1cb7ec96edcf8b117b190696ce5a44b5b4fdb6bdee60923a4993ad4671bae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-7503-9896
0000-0003-3067-7349
0000-0003-3923-1773
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0954611123001087
PMID 36997098
PQID 2793989097
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2793989097
crossref_primary_10_1016_j_rmed_2023_107220
pubmed_primary_36997098
elsevier_sciencedirect_doi_10_1016_j_rmed_2023_107220
PublicationCentury 2000
PublicationDate June 2023
2023-06-00
20230601
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: June 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Respiratory medicine
PublicationTitleAlternate Respir Med
PublicationYear 2023
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Moua, Westerly, Dulohery, Daniels, Ryu, Lim (bib3) 2016 May; 149
(bib32) 2020
Arnold, Attwood, Barratt, Morley, Elvers, McKernon (bib33) 2021 Jul; 38
Hanley, McNeil (bib20) 1982 Apr 1; 143
Collard, Yow, Richeldi, Anstrom, Glazer (bib27) 2013 Jul 13; 14
Petnak, Lertjitbanjong, Thongprayoon, Moua (bib30) 2021 Nov; 160
Kolb, Bondue, Pesci, Miyazaki, Song, Bhatt (bib5) 2018 Dec 31; 27
Kreuter, Koegler, Trampisch, Geier, Richeldi (bib31) 2019 Apr 11; 20
bib15
Arai, Kagawa, Sasaki, Sugawara, Sugimoto, Tachibana (bib25) 2016 Nov; 21
Ley, Ryerson, Vittinghoff, Ryu, Tomassetti, Lee (bib18) 2012 May 15; 156
Song, Hong, Lim, Koh, Kim (bib28) 2011 Feb 1; 37
Harris, Taylor, Thielke, Payne, Gonzalez, Conde (bib16) 2009 Apr; 42
Smith, Prytherch, Jarvis, Kovacs, Meredith, Schmidt (bib19) 2016 Dec; 44
Suzuki, Kondoh, Brown, Johkoh, Kataoka, Fukuoka (bib29) 2020; 25
Collard, Ryerson, Corte, Jenkins, Kondoh, Lederer (bib1) 2016 Aug 1; 194
Smith, Chiovaro, O'Neil, Kansagara, Quiñones, Freeman (bib11) 2014 Nov; 11
Smith, Prytherch, Meredith, Schmidt (bib12) 2015; 28
Kim, Song, Kim, Park, Kim, Oh (bib13) 2020 Mar 31; 7
Salonen, Vähänikkilä, Purokivi, Kaarteenaho (bib22) 2020 Nov 30; 15
Southern (bib6) 2020 Jun 18
Collard, Moore, Flaherty, Brown, Kaner, King (bib23) 2007 Oct 1; 176
Lim, van der Eerden, Laing, Boersma, Karalus, Town (bib9) 2003 May; 58
Yamazaki, Nishiyama, Yoshikawa, Saeki, Sano, Iwanaga (bib21) 2021 Feb 16; 11
Cao, Sheng, Qiu, Wang, Wang, Wang (bib26) 2019 Nov 14; 19
Drake, Docherty, Harrison, Quint, Adamali, Agnew (bib8) 2020 Dec 15; 202
Teramachi, Kondoh, Kataoka, Taniguchi, Matsuda, Kimura (bib14) 2018 Oct; 143
Kolb, Collard (bib17) 2014 Jun; 23
Kondoh, Cottin, Brown (bib24) 2017 Sep 30; 26
Chang, Sullivan, Karalus, Mills, McLachlan, Hancox (bib10) 2011 Jan; 16
Esposito, Menon, Ghosh, Putman, Fredenburgh, El-Chemaly (bib7) 2020 Dec 15; 202
Hyams, Hettle, Bibby, Adamali, Barratt (bib4) 2021; 114
Cottin, Schmidt, Catella, Porte, Fernandez-Montoya, Le Lay (bib2) 2017; 12
Alqahtani, Oyelade, Aldhahir, Gonçalves Mendes, Alghamdi, Miravitlles (bib34) 2021; 16
Arai (10.1016/j.rmed.2023.107220_bib25) 2016; 21
Harris (10.1016/j.rmed.2023.107220_bib16) 2009; 42
Kondoh (10.1016/j.rmed.2023.107220_bib24) 2017; 26
Alqahtani (10.1016/j.rmed.2023.107220_bib34) 2021; 16
Teramachi (10.1016/j.rmed.2023.107220_bib14) 2018; 143
Arnold (10.1016/j.rmed.2023.107220_bib33) 2021; 38
Lim (10.1016/j.rmed.2023.107220_bib9) 2003; 58
Ley (10.1016/j.rmed.2023.107220_bib18) 2012; 156
Yamazaki (10.1016/j.rmed.2023.107220_bib21) 2021; 11
Smith (10.1016/j.rmed.2023.107220_bib12) 2015; 28
Cottin (10.1016/j.rmed.2023.107220_bib2) 2017; 12
Collard (10.1016/j.rmed.2023.107220_bib23) 2007; 176
Kim (10.1016/j.rmed.2023.107220_bib13) 2020; 7
Salonen (10.1016/j.rmed.2023.107220_bib22) 2020; 15
(10.1016/j.rmed.2023.107220_bib32) 2020
Kreuter (10.1016/j.rmed.2023.107220_bib31) 2019; 20
Kolb (10.1016/j.rmed.2023.107220_bib5) 2018; 27
Hanley (10.1016/j.rmed.2023.107220_bib20) 1982; 143
Smith (10.1016/j.rmed.2023.107220_bib11) 2014; 11
Song (10.1016/j.rmed.2023.107220_bib28) 2011; 37
Collard (10.1016/j.rmed.2023.107220_bib1) 2016; 194
Collard (10.1016/j.rmed.2023.107220_bib27) 2013; 14
Suzuki (10.1016/j.rmed.2023.107220_bib29) 2020; 25
Esposito (10.1016/j.rmed.2023.107220_bib7) 2020; 202
Chang (10.1016/j.rmed.2023.107220_bib10) 2011; 16
Hyams (10.1016/j.rmed.2023.107220_bib4) 2021; 114
Southern (10.1016/j.rmed.2023.107220_bib6) 2020
Moua (10.1016/j.rmed.2023.107220_bib3) 2016; 149
Drake (10.1016/j.rmed.2023.107220_bib8) 2020; 202
Smith (10.1016/j.rmed.2023.107220_bib19) 2016; 44
Petnak (10.1016/j.rmed.2023.107220_bib30) 2021; 160
Cao (10.1016/j.rmed.2023.107220_bib26) 2019; 19
Kolb (10.1016/j.rmed.2023.107220_bib17) 2014; 23
References_xml – volume: 12
  year: 2017
  ident: bib2
  article-title: Burden of idiopathic pulmonary fibrosis progression: a 5-year longitudinal follow-up study
  publication-title: PLoS One
  contributor:
    fullname: Le Lay
– volume: 143
  start-page: 29
  year: 1982 Apr 1
  end-page: 36
  ident: bib20
  article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve
  publication-title: Radiology
  contributor:
    fullname: McNeil
– volume: 149
  start-page: 1205
  year: 2016 May
  end-page: 1214
  ident: bib3
  article-title: Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis
  publication-title: Chest
  contributor:
    fullname: Lim
– volume: 27
  year: 2018 Dec 31
  ident: bib5
  article-title: Acute exacerbations of progressive-fibrosing interstitial lung diseases
  publication-title: Eur. Respir. Rev.
  contributor:
    fullname: Bhatt
– volume: 11
  start-page: 1454
  year: 2014 Nov
  end-page: 1465
  ident: bib11
  article-title: Early warning system scores for clinical deterioration in hospitalized patients: a systematic review
  publication-title: Ann Am Thorac Soc
  contributor:
    fullname: Freeman
– volume: 58
  start-page: 377
  year: 2003 May
  end-page: 382
  ident: bib9
  article-title: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
  publication-title: Thorax
  contributor:
    fullname: Town
– volume: 37
  start-page: 356
  year: 2011 Feb 1
  end-page: 363
  ident: bib28
  article-title: Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
  publication-title: Eur. Respir. J.
  contributor:
    fullname: Kim
– volume: 23
  start-page: 220
  year: 2014 Jun
  end-page: 224
  ident: bib17
  article-title: Staging of idiopathic pulmonary fibrosis: past, present and future
  publication-title: Eur. Respir. Rev.
  contributor:
    fullname: Collard
– volume: 16
  start-page: 146
  year: 2011 Jan
  end-page: 151
  ident: bib10
  article-title: Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score
  publication-title: Respirology
  contributor:
    fullname: Hancox
– volume: 143
  start-page: 147
  year: 2018 Oct
  end-page: 152
  ident: bib14
  article-title: Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis
  publication-title: Respir. Med.
  contributor:
    fullname: Kimura
– ident: bib15
  article-title: ISRCTN - ISRCTN17354061: a pan-pandemic respiratory infection surveillance study
– volume: 7
  start-page: 61
  year: 2020 Mar 31
  end-page: 66
  ident: bib13
  article-title: Use of the National Early Warning Score for predicting in-hospital mortality in older adults admitted to the emergency department
  publication-title: Clinical and Experimental Emergency Medicine
  contributor:
    fullname: Oh
– volume: 38
  start-page: 543
  year: 2021 Jul
  end-page: 548
  ident: bib33
  article-title: Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study
  publication-title: Emerg. Med. J.
  contributor:
    fullname: McKernon
– volume: 44
  start-page: 2171
  year: 2016 Dec
  end-page: 2181
  ident: bib19
  article-title: A comparison of the ability of the physiologic components of medical emergency team criteria and the U.K. National early warning score to discriminate patients at risk of a range of adverse clinical outcomes
  publication-title: Crit. Care Med.
  contributor:
    fullname: Schmidt
– volume: 14
  start-page: 73
  year: 2013 Jul 13
  ident: bib27
  article-title: For the IPFnet investigators. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
  publication-title: Respir. Res.
  contributor:
    fullname: Glazer
– volume: 160
  start-page: 1751
  year: 2021 Nov
  end-page: 1763
  ident: bib30
  article-title: Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
  publication-title: Chest
  contributor:
    fullname: Moua
– volume: 26
  year: 2017 Sep 30
  ident: bib24
  article-title: Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
  publication-title: Eur. Respir. Rev.
  contributor:
    fullname: Brown
– volume: 202
  start-page: 1656
  year: 2020 Dec 15
  end-page: 1665
  ident: bib8
  article-title: Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: Agnew
– volume: 202
  start-page: 1710
  year: 2020 Dec 15
  end-page: 1713
  ident: bib7
  article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: El-Chemaly
– volume: 15
  year: 2020 Nov 30
  ident: bib22
  article-title: Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
  publication-title: PLoS One
  contributor:
    fullname: Kaarteenaho
– volume: 21
  start-page: 1431
  year: 2016 Nov
  end-page: 1437
  ident: bib25
  article-title: Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
  publication-title: Respirology
  contributor:
    fullname: Tachibana
– volume: 156
  start-page: 684
  year: 2012 May 15
  end-page: 691
  ident: bib18
  article-title: A multidimensional index and staging system for idiopathic pulmonary fibrosis
  publication-title: Ann. Intern. Med.
  contributor:
    fullname: Lee
– volume: 176
  start-page: 636
  year: 2007 Oct 1
  end-page: 643
  ident: bib23
  article-title: Acute exacerbations of idiopathic pulmonary fibrosis
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: King
– volume: 194
  start-page: 265
  year: 2016 Aug 1
  end-page: 275
  ident: bib1
  article-title: Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
  publication-title: Am. J. Respir. Crit. Care Med.
  contributor:
    fullname: Lederer
– year: 2020 Jun 18
  ident: bib6
  article-title: Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19
  publication-title: Cleve. Clin. J. Med.
  contributor:
    fullname: Southern
– volume: 28
  start-page: 872
  year: 2015
  end-page: 875
  ident: bib12
  article-title: Early warning scores: unravelling detection and escalation
  publication-title: Int. J. Health Care Qual. Assur.
  contributor:
    fullname: Schmidt
– volume: 114
  start-page: 559
  year: 2021
  end-page: 567
  ident: bib4
  article-title: Utility of illness severity scores to predict mortality in patients hospitalized with respiratory deterioration of idiopathic pulmonary fibrosis
  publication-title: QJM: Int. J. Med.
  contributor:
    fullname: Barratt
– volume: 19
  start-page: 215
  year: 2019 Nov 14
  ident: bib26
  article-title: Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
  publication-title: BMC Pulm. Med.
  contributor:
    fullname: Wang
– volume: 11
  start-page: 3880
  year: 2021 Feb 16
  ident: bib21
  article-title: Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
  publication-title: Sci. Rep.
  contributor:
    fullname: Iwanaga
– year: 2020
  ident: bib32
  publication-title: Over a third of people with lung conditions felt pressure to avoid or delay seeking treatment during lockdown
– volume: 25
  start-page: 525
  year: 2020
  end-page: 534
  ident: bib29
  article-title: Acute exacerbations of fibrotic interstitial lung diseases
  publication-title: Respirology
  contributor:
    fullname: Fukuoka
– volume: 16
  year: 2021
  ident: bib34
  article-title: Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis
  publication-title: PLoS One
  contributor:
    fullname: Miravitlles
– volume: 42
  start-page: 377
  year: 2009 Apr
  end-page: 381
  ident: bib16
  article-title: Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support
  publication-title: J. Biomed. Inf.
  contributor:
    fullname: Conde
– volume: 20
  start-page: 71
  year: 2019 Apr 11
  ident: bib31
  article-title: Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
  publication-title: Respir. Res.
  contributor:
    fullname: Richeldi
– volume: 14
  start-page: 73
  issue: 1
  year: 2013
  ident: 10.1016/j.rmed.2023.107220_bib27
  article-title: For the IPFnet investigators. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials
  publication-title: Respir. Res.
  doi: 10.1186/1465-9921-14-73
  contributor:
    fullname: Collard
– volume: 176
  start-page: 636
  issue: 7
  year: 2007
  ident: 10.1016/j.rmed.2023.107220_bib23
  article-title: Acute exacerbations of idiopathic pulmonary fibrosis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200703-463PP
  contributor:
    fullname: Collard
– year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib6
  article-title: Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19
  publication-title: Cleve. Clin. J. Med.
  doi: 10.3949/ccjm.87a.ccc026
  contributor:
    fullname: Southern
– volume: 11
  start-page: 1454
  issue: 9
  year: 2014
  ident: 10.1016/j.rmed.2023.107220_bib11
  article-title: Early warning system scores for clinical deterioration in hospitalized patients: a systematic review
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.201403-102OC
  contributor:
    fullname: Smith
– volume: 58
  start-page: 377
  issue: 5
  year: 2003
  ident: 10.1016/j.rmed.2023.107220_bib9
  article-title: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
  publication-title: Thorax
  doi: 10.1136/thorax.58.5.377
  contributor:
    fullname: Lim
– volume: 160
  start-page: 1751
  issue: 5
  year: 2021
  ident: 10.1016/j.rmed.2023.107220_bib30
  article-title: Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
  publication-title: Chest
  doi: 10.1016/j.chest.2021.06.049
  contributor:
    fullname: Petnak
– volume: 11
  start-page: 3880
  issue: 1
  year: 2021
  ident: 10.1016/j.rmed.2023.107220_bib21
  article-title: Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-83381-z
  contributor:
    fullname: Yamazaki
– volume: 21
  start-page: 1431
  issue: 8
  year: 2016
  ident: 10.1016/j.rmed.2023.107220_bib25
  article-title: Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
  publication-title: Respirology
  doi: 10.1111/resp.12862
  contributor:
    fullname: Arai
– volume: 23
  start-page: 220
  issue: 132
  year: 2014
  ident: 10.1016/j.rmed.2023.107220_bib17
  article-title: Staging of idiopathic pulmonary fibrosis: past, present and future
  publication-title: Eur. Respir. Rev.
  doi: 10.1183/09059180.00002114
  contributor:
    fullname: Kolb
– volume: 7
  start-page: 61
  year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib13
  article-title: Use of the National Early Warning Score for predicting in-hospital mortality in older adults admitted to the emergency department
  publication-title: Clinical and Experimental Emergency Medicine
  doi: 10.15441/ceem.19.036
  contributor:
    fullname: Kim
– volume: 27
  issue: 150
  year: 2018
  ident: 10.1016/j.rmed.2023.107220_bib5
  article-title: Acute exacerbations of progressive-fibrosing interstitial lung diseases
  publication-title: Eur. Respir. Rev.
  doi: 10.1183/16000617.0071-2018
  contributor:
    fullname: Kolb
– volume: 16
  year: 2021
  ident: 10.1016/j.rmed.2023.107220_bib34
  article-title: Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0255659
  contributor:
    fullname: Alqahtani
– volume: 16
  start-page: 146
  issue: 1
  year: 2011
  ident: 10.1016/j.rmed.2023.107220_bib10
  article-title: Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2010.01866.x
  contributor:
    fullname: Chang
– volume: 42
  start-page: 377
  issue: 2
  year: 2009
  ident: 10.1016/j.rmed.2023.107220_bib16
  article-title: Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support
  publication-title: J. Biomed. Inf.
  doi: 10.1016/j.jbi.2008.08.010
  contributor:
    fullname: Harris
– year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib32
– volume: 114
  start-page: 559
  issue: 8
  year: 2021
  ident: 10.1016/j.rmed.2023.107220_bib4
  article-title: Utility of illness severity scores to predict mortality in patients hospitalized with respiratory deterioration of idiopathic pulmonary fibrosis
  publication-title: QJM: Int. J. Med.
  doi: 10.1093/qjmed/hcaa214
  contributor:
    fullname: Hyams
– volume: 202
  start-page: 1656
  issue: 12
  year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib8
  article-title: Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.202007-2794OC
  contributor:
    fullname: Drake
– volume: 20
  start-page: 71
  issue: 1
  year: 2019
  ident: 10.1016/j.rmed.2023.107220_bib31
  article-title: Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
  publication-title: Respir. Res.
  doi: 10.1186/s12931-019-1037-7
  contributor:
    fullname: Kreuter
– volume: 149
  start-page: 1205
  issue: 5
  year: 2016
  ident: 10.1016/j.rmed.2023.107220_bib3
  article-title: Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis
  publication-title: Chest
  doi: 10.1016/j.chest.2015.12.026
  contributor:
    fullname: Moua
– volume: 44
  start-page: 2171
  issue: 12
  year: 2016
  ident: 10.1016/j.rmed.2023.107220_bib19
  article-title: A comparison of the ability of the physiologic components of medical emergency team criteria and the U.K. National early warning score to discriminate patients at risk of a range of adverse clinical outcomes
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000002000
  contributor:
    fullname: Smith
– volume: 202
  start-page: 1710
  issue: 12
  year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib7
  article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.202006-2441LE
  contributor:
    fullname: Esposito
– volume: 15
  issue: 11
  year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib22
  article-title: Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0242860
  contributor:
    fullname: Salonen
– volume: 38
  start-page: 543
  issue: 7
  year: 2021
  ident: 10.1016/j.rmed.2023.107220_bib33
  article-title: Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study
  publication-title: Emerg. Med. J.
  doi: 10.1136/emermed-2020-210380
  contributor:
    fullname: Arnold
– volume: 156
  start-page: 684
  issue: 10
  year: 2012
  ident: 10.1016/j.rmed.2023.107220_bib18
  article-title: A multidimensional index and staging system for idiopathic pulmonary fibrosis
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-156-10-201205150-00004
  contributor:
    fullname: Ley
– volume: 25
  start-page: 525
  issue: 5
  year: 2020
  ident: 10.1016/j.rmed.2023.107220_bib29
  article-title: Acute exacerbations of fibrotic interstitial lung diseases
  publication-title: Respirology
  doi: 10.1111/resp.13682
  contributor:
    fullname: Suzuki
– volume: 143
  start-page: 29
  issue: 1
  year: 1982
  ident: 10.1016/j.rmed.2023.107220_bib20
  article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve
  publication-title: Radiology
  doi: 10.1148/radiology.143.1.7063747
  contributor:
    fullname: Hanley
– volume: 194
  start-page: 265
  issue: 3
  year: 2016
  ident: 10.1016/j.rmed.2023.107220_bib1
  article-title: Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201604-0801CI
  contributor:
    fullname: Collard
– volume: 143
  start-page: 147
  year: 2018
  ident: 10.1016/j.rmed.2023.107220_bib14
  article-title: Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2018.09.011
  contributor:
    fullname: Teramachi
– volume: 37
  start-page: 356
  issue: 2
  year: 2011
  ident: 10.1016/j.rmed.2023.107220_bib28
  article-title: Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.00159709
  contributor:
    fullname: Song
– volume: 12
  issue: 1
  year: 2017
  ident: 10.1016/j.rmed.2023.107220_bib2
  article-title: Burden of idiopathic pulmonary fibrosis progression: a 5-year longitudinal follow-up study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0166462
  contributor:
    fullname: Cottin
– volume: 19
  start-page: 215
  issue: 1
  year: 2019
  ident: 10.1016/j.rmed.2023.107220_bib26
  article-title: Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
  publication-title: BMC Pulm. Med.
  doi: 10.1186/s12890-019-0960-1
  contributor:
    fullname: Cao
– volume: 28
  start-page: 872
  issue: 8
  year: 2015
  ident: 10.1016/j.rmed.2023.107220_bib12
  article-title: Early warning scores: unravelling detection and escalation
  publication-title: Int. J. Health Care Qual. Assur.
  doi: 10.1108/IJHCQA-07-2015-0086
  contributor:
    fullname: Smith
– volume: 26
  issue: 145
  year: 2017
  ident: 10.1016/j.rmed.2023.107220_bib24
  article-title: Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
  publication-title: Eur. Respir. Rev.
  doi: 10.1183/16000617.0050-2017
  contributor:
    fullname: Kondoh
SSID ssj0009440
Score 2.4343398
Snippet Hospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting adverse outcomes...
INTRODUCTIONHospitalisations relating to acute respiratory deteriorations (ARD) in Interstitial Lung Disease (ILD) have poor outcomes. Factors predicting...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 107220
SubjectTerms Acute respiratory deterioration
Adult
Hospital Mortality
Humans
Interstitial lung disease
Lung Diseases, Interstitial
Patient Acuity
Prognosis
Prospective Studies
Pulmonary fibrosis
Retrospective Studies
ROC Curve
Severity of Illness Index
Severity scores
Title Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration
URI https://dx.doi.org/10.1016/j.rmed.2023.107220
https://www.ncbi.nlm.nih.gov/pubmed/36997098
https://search.proquest.com/docview/2793989097
Volume 212
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbarYS4IN4s0MpI3FC6ceI48bGqqLZF7QVW6s3yY1YELdlVkr3yB_jTzCQOFRL0wDGOnVieyefPmRdj7yWVoqkKmYR1mibSCpc4q2WSh9IHUMqKnIKTr2_UciWvbovbA3Y-xcKQW2XE_hHTB7SOLYu4motdXS8-IzmQCj9VJNF4qKjKQ3Y0GIlm7Ojs8tPy5i73rhziIql_QgNi7Mzo5tXipnNKNcSxocyo7Pff96d_8c9hH7p4zB5FAsnPxjk-YQfQPGUPrqOJ_Bn7ueqAb9e83mwIxTg-GahAHe8oYWXH-y3ftdS7598H6k336oZT3oiWHAdQIfkGIYBH2w2PqVc7_jXWGMH2wOkHLrd-3wNv78z1PJB7TR316jlbXXz8cr5MYsWFxOeF6BOVe-FdCV4rCH5dOSFKh5RBaeWhsFK6wsl1cMoFAJUiObR4YsptQLgVzkL-gs2abQOvGMdjmHaVz50AJ7MA2leQZd6nIBzozM_Zh2mdzW5MrGEmj7NvhqRiSCpmlMqcFZMozB_qYRD57x33bpKbwe-GjCG2ge2-MxkCk650qss5ezkK9Pc8cqV1merq9X--9Q17SFejR9lbNuvbPRwjd-ndCTs8_SFOoob-Ah-x8b0
link.rule.ids 315,783,787,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXxJvlaSRuKN04cZz4iCqqBbq90JV6s_yYVYOW7CrJXvsH-NPMJA4VEnDgajuJ5Rl__px5MfZOUimaqpBJWKdpIq1wibNaJnkofQClrMgpOHl5rhYr-fmyuDxgJ1MsDLlVRuwfMX1A69gyj6s539X1_CuSA6lwqyKJxktFVd5ityXlz0KlPr6-8fPQcoiKpNEJDY-RM6OTV4tHzjFVEMeGMqOi338-nf7GPodT6PQ-uxfpI_8wzvABO4DmIbuzjAbyR-zHqgO-XfN6syEM4_hmoPJ0vKN0lR3vt3zX0uiefx-IN_XVDaesES25DaA68g0CAI-WGx4Tr3b8KlYYwfbA6fctt37fA29vjPU8kHNNHbXqMVudfrw4WSSx3kLi80L0icq98K4ErxUEv66cEKVDwqC08lBYKV3h5Do45QKASpEaWrwv5TYg2ApnIX_CDpttA88Yx0uYdpXPnQAnswDaV5Bl3qcgHOjMz9j7aZ3NbkyrYSZ_s2-GpGJIKmaUyowVkyjMb8phEPf_-dzbSW4Gdw2ZQmwD231nMoQlXelUlzP2dBTor3nkSusy1dXz__zqG3Z3cbE8M2efzr-8YEfUM_qWvWSHfbuHV8hievd60NKfbyXynw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+illness+severity+scores+to+predict+mortality+in+interstitial+lung+disease+patients+hospitalised+with+acute+respiratory+deterioration&rft.jtitle=Respiratory+medicine&rft.au=Williams%2C+Rachel+L&rft.au=Hyams%2C+Catherine&rft.au=Robertshaw%2C+Joe&rft.au=Gonzalez%2C+Maria+Garcia&rft.date=2023-06-01&rft.eissn=1532-3064&rft.volume=212&rft.spage=107220&rft.epage=107220&rft_id=info:doi/10.1016%2Fj.rmed.2023.107220&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6111&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6111&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6111&client=summon